Abbott Labs stock hit a 52-week low after an earnings miss, but CEO Robert Ford isn't flinching. Here is why his $2 million ...
CEO Robert Ford made his first purchase of company stock since March.
Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast higher full-year profits and steady sales growth.
By Christy Santhosh and Kamal Choudhury Jan 22 (Reuters) - Abbott forecast current-quarter profit below estimates after ...
The Medical Devices business remained a standout performer at Abbott, with Q4 sales up 12.3% to $5.68 billion. Though BTIG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results